Clinical Trials Directory

Trials / Completed

CompletedNCT00544921

Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects

Phase 1 Study of Anti-glycation Agent GLY-230

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Glycadia · Industry
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

To test the safety of GLY-230 and to evaluate how long drug stays in blood after taking it by mouth.

Conditions

Interventions

TypeNameDescription
DRUGGLY-230
OTHERPlaceboNo drug administered

Timeline

Start date
2005-10-01
Primary completion
2006-10-01
Completion
2006-10-01
First posted
2007-10-16
Last updated
2016-02-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00544921. Inclusion in this directory is not an endorsement.